May 17, 2022May 17, 2022 ANG-3070 is a Highly-Selective, Orally-Available TKI in Development for Pulmonary and Renal Fibrosis
November 5, 2021November 5, 2021 Phase 2 Study Design to Evaluate Safety and Efficacy of the Tyrosine Kinase Inhibitor ANG-3070 in Patients with Primary Proteinuric Kidney Disease
November 4, 2021November 4, 2021 Effect of ANG-3070 in the Passive Heymann’s Nephritis Rat Model of Primary Proteinuric Kidney Disease
November 4, 2021November 4, 2021 Effect of ANG-3070 in the Unilateral Ureteral Obstruction Mouse Model of Renal Fibrosis
June 4, 2021November 5, 2021 Costs in the Year Following Deceased Donor Kidney Transplantation: Relationships with Renal Function and Graft Failure
October 30, 2020February 5, 2021 Hepatocyte Growth Factor Mimetic ANG-3777 for Cardiac Surgery–Associated Acute Kidney Injury
October 22, 2020February 5, 2021 The Effect of ANG-3777 on the Growth of c-Met Expressing Tumor Cells in Immunocompromised Mice
October 22, 2020February 5, 2021 Defining a Clinically-Meaningful Difference (MCMD) in Estimated Glomerular Filtration Rate (eGFR) for Kidney Transplantation
